{
    "id": 27176,
    "cites": 14,
    "cited_by": 0,
    "reference": [
        "Abrantes-Metz, R. M., Adams, C. P., & Metz, A. (2004). Pharmaceutical development phases: A duration analysis (Bureau of Economics No. 274). Federal Trade Commission. https://www.ftc.gov/reports/pharmaceutical-development-phases-duration-analysis Andr\u00c3\u0083\u00c2\u00a9, F. E. (2002). How the research-based industry approaches vaccine development and establishes priorities. Developments in Biologicals, 110, 25\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c29.",
        "Davis, M. M., Butchart, A. T., Wheeler, J. R. C., Coleman, M. S., Singer, D. C., & Freed, G. L. (2011). Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline. Vaccine, 29(51), 9414\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c9416. https://doi.org/10.1016/j.vaccine.2011.09.128 DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010). Trends in risks associated with new drug development: Success rates for investigational drugs. Clinical Pharmacology & Therapeutics, 87(3), 272\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c277. https://doi.org/10.1038/clpt.2009.295 DiMasi, J. A., Florez, M. I., Stergiopoulos, S., Pena, Y., Smith, Z., Wilkinson, M., & Getz, K. A.",
        "(2020). Development times and approval success rates for drugs to treat infectious diseases.",
        "Clinical Pharmacology & Therapeutics, 107(2), 324\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c332. https://doi.org/10.1002/cpt.1627 Ehreth, J. (2003). The global value of vaccination. Vaccine, 21(7\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c8), 596\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c600.",
        "Evaluate. (2018, June 6). EvaluatePharma World Preview 2018, Outlook to 2024.",
        "https://www.evaluate.com/PharmaWorldPreview2018 Food and Drug Administration Amendments Act of 2007, H.R. 3580, 110th Cong. (2007).",
        "Food and Drug Administration Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible, 21 C.F.R.  90\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c95 (2019).",
        "Food and Drug Administration Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible, 21 C.F.R.  600\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c650 (2019).",
        "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=314&showF R=1&subpartNode=21:5.0.1.1.4.9 Food and Drug Administration [FDA]. (2015, October). Guidance for industry product development animal rule. https://www.fda.gov/files/drugs/published/Product-DevelopmentUnder -the-Animal-Rule.pdf Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014). Clinical development success rates for investigational drugs. Nature Biotechnology, 32(1), 40\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c51. https://doi.org/10.1038/nbt.2786 13 May 2020  2020 by Lo, Siah, and Wong Page 19 of 25 All Rights Reserved Hensley, S., & Wysocki Jr., B. (2005, November 8). As industry profits elsewhere, U.S. lacks vaccines, antibiotics. The Wall Street Journal.",
        "https://www.wsj.com/articles/SB113141787830190837 Hu, C. (2018, July 21). Major pharmaceutical companies like Novartis dropping antibiotics projects and future tools against superbugs. Business Insider. https://www.businessinsider.com/major-pharmaceutical-companies-dropping-antibiotic-projectssuperbugs -2018-7 Infectious Diseases Society of America. (2019, December 27). CORRECTION: Antibiotic company starts bankruptcy proceedings; Highlights urgent need for investment in infection fighting drugs. https://www.idsociety.org/news--publications-new/articles/2019/CORRECTIONAntibiotic -Company-Starts-Bankruptcy-Proceedings-Highlights-Urgent-Need-for-Investment-inInfection -Fighting-Drugs/ Jacobs, A. (2019, December 25). Crisis looms in antibiotics as drug makers go bankrupt. The New York Times. https://www.nytimes.com/2019/12/25/health/antibiotics-new-resistance.html Kieny, M. P., & Girard, M. P. (2005). Human vaccine research and development: An overview.",
        "Vaccine, 23(50), 5705\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c5707. https://doi.org/10.1016/j.vaccine.2005.07.077 Langreth, R. (2019, May 3). Antibiotics aren\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2t profitable enough for big pharma to make more.",
        "Bloomberg Businessweek. https://www.bloomberg.com/news/articles/2019-05-03/antibioticsaren -t-profitable-enough-for-big-pharma-to-make-more MIT Laboratory for Financial Engineering. (2020). Estimates of clinical trial probabilities of success (PoS) - 2019Q4. Retrieved March 29, 2020, from https://projectalpha.mit.edu/pos/ Organisation for Economic Co-operation and Development. (2013). Health at a glance 2013: OECD indicators. https://doi.org/10.1787/health_glance-2013-en Pronker, E. S., Weenen, T. C., Commandeur, H., Claassen, E. H. J. H. M., & Osterhaus, A. D. M.",
        "https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success %20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf Trefis. (2020). MRK revenues: How does Merck make money? Trefis. https://dashboards.trefis.com/no-login-required/qVh09Fjc/MRK-Revenues-How-Does-MerckMake -MoneyU.",
        "World Health Organization. (1980). The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979. https://apps.who.int/iris/handle/10665/39253 World Health Organization. (2020). Vaccines and diseases. https://www.who.int/immunization/diseases/en/ Young, R., Bekele, T., Gunn, A., Chapman, N., Chowdhary, V., Corrigan, K., Dahora, L., Martinez, S., Permar, S., Persson, J., Rodriguez, B., Sch\u00c3\u0083\u00c2\u00a4ferhoff, M., Schulman, K., Singh, T., Terry, R. F., & Yamey, G. (2020). Developing new health technologies for neglected diseases: A pipeline portfolio review and cost model. Gates Open Research, 2, 23. https://doi.org/10.12688/gatesopenres.12817.3 13 May 2020  2020 by Lo, Siah, and Wong Page 21 of 25 All Rights Reserved"
    ]
}